Table 2 Correlation of miR-216b expression in HCC with 50 patients’ clinical and pathological properties
Parameters | Low miR-216b expression (N=90) | High miR-216b expression (N=60) | χ 2 -Test |
|---|---|---|---|
Gender | Male (42)-46.7% | Male (24)-40% | P=0.861 |
| Â | Female (48)-53.3% | Female (36)-60% | Â |
Age | ≥60 (57)-63.3% | ≥60 (24)-40% | P=0.183 |
| Â | <60 (33)-36.7% | <60 (36)-60% | Â |
Tumor size | ≥5 cm (42)-46.7% | ≥5 cm (9)-15% | P=0.044* |
| Â | <5 cm (48)-53.3% | <5 cm (51)-85% | Â |
Hepatitis infection | Infected (72)-80% | Infected (30)-50% | P=0.026* |
| Â | Not infected (18)-20% | Not infected (30)-50% | Â |
HBV DNA quantity differentiation | ≥1000 (63)-70% | ≥1000 (9)-15% | P=0.001* |
| Â | <1000 (27)-30% | <1000 (51)-85% | Â |
| Â | High/moderate (60)-66.7% | High/moderate (48)-80% | P=0.479 |
| Â | Low (30)-33.3% | Low (12)-20% | Â |
Cirrhosis | Present (36)-40% | Present (18)-30% | P=0.674 |
| Â | Absent (54)-60% | Absent (42)-70% | Â |
PVTT | Present (45)-50% | Present (12)-30% | P=0.032* |
| Â | Absent (45)-50% | Absent (48)-70% | Â |
AFP level>200 ug/l | Yes (33)-36.7% | Yes (15)-25% | P=0.578 |
| Â | No (57)-63.3% | No (45)-75% | Â |
Child–Pugh score | A (81)-90% | A (57)-95% | P=0.741 |
| Â | B (9)-10% | B (3)-5% | Â |
